severe B-Symptom | pain I-Symptom | and O | severe B-Symptom | limitation I-Symptom | in O | movement O | in O | upper B-Disease | arm I-Disease | muscles O | ; O | memory B-Symptom | deficits I-Symptom | and O | mental B-Symptom | fogginess I-Symptom | ; O | worsening B-Symptom | cataract I-Disease | ; O | parkinson's-type B-Disease | tremor I-Disease | in O | left B-Disease | hand I-Disease | . O | Two O | weeks O | after O | discontinuing O | mevacor B-Drug | , O | the O | muscle B-Symptom | pain I-Symptom | was O | very O | much O | improved O | ( O | full O | range O | of O | motion O | took O | a O | year O | to O | recover O | ) O | ; O | tremor B-Symptom | disappeared O | ; O | vision B-Symptom | in O | eye O | awaiting O | cataract B-Disease | surgery O | improved O | to O | pre-Mevacor B-Drug | level O | ( O | my O | eye O | surgeon O | said O | that O | he O | had O | seen O | existing O | cataracts B-Disease | made O | more O | severe O | by O | statins B-Drug | in O | other O | patients O | as O | well O | ) O | ; O | noticed O | distinct O | improvement O | mental B-Symptom | function I-Symptom | in O | two O | weeks O | . O | There O | have O | been O | reports O | of O | worsening B-Symptom | of O | gum B-Disease | disease I-Disease | as O | well O | , O | which O | I O | had O | had O | and O | which O | did O | improve O | . O | If O | you O | read O | the O | research O | carefully O | , O | there O | is O | reason O | to O | believe O | that O | higher O | levels O | of O | cholesterol B-Disease | are O | associated O | with O | lower O | overall O | mortality O | rather O | than O | higher O | , O | especially O | in O | older O | women O | . O | Cholesterol B-Disease | is O | an O | important O | part O | of O | brain B-Disease | tissue O | and O | many O | essential O | biochemicals O | , O | and O | that O | serum O | cholesterol B-Disease | levels O | do O | not O | correlate O | well O | with O | arterial O | placque O | . O |